Home/ Supplements/ Vitamin A/ Geri-Freeda Senior Formula

Geri-Freeda Senior Formula

product on market Tablet or Pill Freeda Safety: 97/100
97/100

This product looks safe

  • Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • Folate: 667mg is 667.0× the Tolerable Upper Intake Level (1.0mg)
  • 72% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains essential vitamins A, C, D, E, and B1, which support immune function, bone health, and cellular metabolism. There is strong evidence for the role of these nutrients in maintaining general physiological health in older adults. The product maintains a high safety profile based on available data.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)

Folate: 667mg is 667.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Geri-Freeda Senior Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Other Combinations
Product Type
72%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
675 mcg (75% DV)
Vitamin C
150 mg (167% DV)
20 mcg (100% DV)
1.3× RDA — within safe limits 608 studies (A:16, B:251)
10 mg (67% DV)
Within RDA (0.7× RDA) 179 studies (A:3, B:90)
15 mg (1250% DV)
12.5× RDA — above typical dose 76 studies (A:0, B:33)
15 mg (1154% DV)
11.5× RDA — above typical dose 13 studies (A:0, B:1)
50 mg (313% DV)
Exceeds UL by 1.4× (UL: 35 mg) 196 studies (A:5, B:63)
15 mg (882% DV)
11.5× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
667 mcg DFE (167% DV)
Exceeds UL by 667.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
15 mcg (625% DV)
6.2× RDA — above typical dose 139 studies (A:1, B:44)
15 mcg (50% DV)
Within RDA (0.5× RDA) 27 studies (A:0, B:11)
15 mg (300% DV)
3.0× RDA — within safe limits 2 studies — no high-quality reviews
Calcium
30 mg (2% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
25 mg (6% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
7.5 mg (68% DV)
Within RDA (0.7× RDA) 263 studies (A:6, B:134)
35 mcg (64% DV)
Within RDA (0.6× RDA) 173 studies (A:0, B:67)
0.5 mg (56% DV)
Within RDA (0.6× RDA) 37 studies (A:0, B:11)
1 mg (43% DV)
Within RDA (0.4× RDA) 9 studies — no high-quality reviews
60 mcg (171% DV)
1.7× RDA — within safe limits 199 studies (A:1, B:55)
10 mg (2% DV)
Market median: 125.0mg (294 products) 38 studies (A:1, B:7)
10 mg
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
Hesperidin
10 mg
10 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)

Other Ingredients

Cellulose Calcium Phosphate Vegetarian Stearate Vegetable Glycerin Coating Silica Croscarmellose Sodium
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: Adults, take one (1) tablet daily, preferably with food and liquid.

Warnings & Precautions

Keep out of the reach of children.

Formulation Notes

No gluten No lactose No artificial colors No artificial flavors No animal derivatives No sugar or starch No gelatin No yeast

Vegan

NSKC (New Square Rabbinical Kashrus Council) OU Pareve (Kosher)

Additional Information

Manufactured in a GMP certified facility in the USA

Freeda since 1928

NSKC (New Square Rabbinical Kashrus Council) OU Pareve (Kosher)

Store product at room temperature. Do not expose to excessive heat or moisture.

Metadata

Product Details

UPC / SKU7 58487 00182 8
DSLD Entry Date2020-05-22
Product TypeOther Combinations
FormTablet or Pill
BrandFreeda
DSLD ID221324
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.